This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Baum, M. A clinical trial of mithramycin in the treatment of advanced malignant disease. Br J Cancer 22, 176–183 (1968). https://doi.org/10.1038/bjc.1968.25
Issue Date:
DOI: https://doi.org/10.1038/bjc.1968.25
This article is cited by
-
Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype
Cell Death & Disease (2021)
-
Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma
Laboratory Investigation (2019)
-
Treatment of malignancy-associated hypercalcemia with 1-hydroxyethylidene diphosphonate (EHDP) or actinomycin D
Journal of Bone and Mineral Metabolism (1988)